Skip to main content
. 2022 Mar 18;26(1):33–41. doi: 10.4235/agmr.21.0144

Table 2.

Pathological characteristics of patients with gastric cancer in each age group

Group I (young, <65 y) Group II (early old, 65–74 y) Group III (old, ≥75 y) p-valuea) p-valueb)
Number of patients 1680 919 384
Cancer type 0.932 0.349
 EGC 1,219 (72.6) 644 (70.1) 270 (70.3)
 AGC 461 (27.4) 275 (29.9) 114 (29.7)
Lauren histologic type 0.201 <0.001*
 Intestinal 856 (51.0) 687 (74.8) 300 (78.1)
 Diffuse 749 (44.6) 194 (21.1) 71 (18.5)
 Mixed 75 (4.4) 38 (4.1) 13 (3.4)
Tumor location 0.687 <0.001*
 Upper 36 (2.1) 22 (2.4) 19 (5.0)
 Middle 828 (49.3) 373 (40.6) 131 (34.1)
 Lower 816 (48.6) 524 (57.0) 234 (60.9)
Surgical methods 0.504
 Subtotal gastrectomy 1,325 (78.9) 712 (77.5) 300 (78.1)
 Proximal gastrectomy 66 (3.9) 31 (3.4) 18 (4.7)
 Pylorus-preserving gastrectomy 10 (0.6) 5 (0.5) 1 (0.3)
 Total gastrectomy 279 (16.6) 171 (18.6) 65 (16.9)
Node metastasis 0.498 0.779
 Negative 1,245 (74.1) 689 (75.0) 281 (73.2)
 Positive 435 (25.9) 230 (25.0) 103 (26.8)
Cancer stage 0.273 0.471
 I 1,310 (78.0) 711 (77.4) 291 (75.7)
 II 225 (13.4) 129 (14.0) 51 (13.3)
 III 112 (6.6) 66 (7.2) 34 (8.9)
 IV 33 (2.0) 13 (1.4) 8 (2.1)
p53 overexpression 0.099 0.004*
 Negative 1,117 (66.5) 551 (60.0) 249 (64.8)
 Positive 563 (33.5) 368 (40.0) 135 (35.2)

Values are presented as number (%).

EGC, early gastric cancer; AGC, advanced gastric cancer.

a)

Between young-old and old-old groups,

b)

among all age groups.

*

p<0.05.